Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AHNP Precision Health, operating as Apollo Health, is a precision medicine company dedicated to the prevention and reversal of cognitive decline. The company's core offering is based on the Bredesen Protocol, a comprehensive, personalized program developed by Dr. Dale Bredesen to address the multiple drivers of Alzheimer's disease. Through its digital platform, the company provides the ReCODE and PreCODE programs, which utilize biochemical testing to generate tailored lifestyle, nutritional, and supplemental interventions. AHNP Precision Health focuses on a systems-biology approach to brain health, moving beyond traditional monotherapy to manage complex neurodegenerative conditions. The company provides tools for both practitioners and individuals to track progress and optimize metabolic health for cognitive function.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AHNP Precision Health.